BII
CASI

Bainco International Investors’s CASI Pharmaceuticals CASI Stock Holding History

Bainco International Investors’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1K Buy
+7
New +$152 ﹤0.01% 216
2020
Q2 		– Sell
-7
Closed – – 110
2020
Q1 		$0 Buy
+7
New +$167 ﹤0.01% 280

Other funds holding CASI

IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bainco International Investors's CASI Position: Q4 2020 in Review

Bainco International Investors opened a new position in CASI Pharmaceuticals (CASI) in Q4 2020: 7 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #216 among its holdings. This is a return to the name: Bainco International Investors previously reported a position in CASI as recently as Q1 2020.

Bainco International Investors first reported a position in CASI in Q1 2020 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold CASI as of Q4 2020.

  • Bainco International Investors held 7 shares of CASI Pharmaceuticals worth $1K as of Q4 2020.
  • CASI Pharmaceuticals was a new Bainco International Investors position in Q4 2020.
  • CASI Pharmaceuticals made up ﹤0.01% of Bainco International Investors's portfolio in Q4 2020, its #216 holding.
  • Bainco International Investors first reported a position in CASI Pharmaceuticals in Q1 2020 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.